A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Trial details
- Registry ID
- NCT05271604
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT05271604 | BioAtla, Inc. | Phase 2 | Completed | 2025-09-22Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |